Article
Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia.
Pharmacogenomics - 1 Oct 2008
Ikeda Masashi, Yamanouchi Yoshio, Kinoshita Yoko, Kitajima Tsuyoshi, Yoshimura Reiji, Hashimoto Shuji, O'Donovan Michael C, Nakamura Jun, Ozaki Norio, Iwata Nakao
Abstract excerpt
AIMS: Abnormalities in dopaminergic and serotonergic transmission systems are thought to be involved in the pathophysiology of schizophrenia and the mechanisms underlying the therapeutic effects of antipsychotics. We conducted a pharmacogenetic study to evaluate whether variants in dopamine-related genes (DRD1-DRD5, AKT1 and GSK3beta) and serotonin receptor genes (HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6 and HTR7)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
